Multiple endogenous receptors and pathways engaged by UC-MSC secreted factors and extracellular vesicles

The therapeutic action of Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSCs) is mediated by a complex secretome consisting of soluble factors and extracellular vesicles (EVs). These components engage multiple endogenous receptors and signaling pathways to exert immunomodulatory, anti-inflammatory, and regenerative effects (Wang et al., 2020, Stem Cell Res Ther). Key molecules within this secretome include transforming growth factor-beta (TGF-β), interleukin-10 (IL-10), and prostaglandin E2 (PGE2), which modulate the activity of T cells, macrophages, and dendritic cells. Additionally, UC-MSC-derived EVs deliver functional microRNAs and proteins that activate survival pathways such as PI3K/Akt and MAPK in damaged tissues (Tang et al., 2021, Front Bioeng Biotechnol). This multi-target mechanism is being investigated for a variety of clinical applications, including graft-versus-host disease, myocardial infarction, and respiratory distress syndromes. Unlike traditional single-target drugs, the UC-MSC secretome provides a holistic approach to tissue homeostasis, though it presents significant challenges in standardization and potency characterization (Weiss and Dahlke, 2019, Lancet).

Other names

UC-MSC secretomeUC-MSC-derived extracellular vesiclesUC-MSC-EVsUmbilical cord mesenchymal stem cell conditioned medium

Activation of multiple anti-inflammatory and regenerative signaling pathways through the paracrine delivery of cytokines, growth factors, and exosomal microRNAs that modulate host cell gene expression and phenotype.